CHEK
Check-Cap Ltd.
Set alert
- YTD
- +87.88%
- 1 year
- +130.20%
- Open
- 1.80
- Prev close
- 1.86
- Mkt cap
- 13.16M
- Vol
- 39.37K
- Avg vol
- 20.07K
- EPS
- -3.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.77
- High
- 1.86
- Forward P/E
- -0.87
- Beta
- 0.18
- Short ratio
- 0.43
- Inst. own
- 0.23%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Dec 23, 2024
- 50-d avg
- 0.96552
- 200-d avg
- 1.77
- 1y target
- 0.00
Key statistics
- Market cap
- 13.16M
- Enterprise value
- -21.31M
- Trailing P/E
- 0.00
- Forward P/E
- -0.87
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.56
- EPS (TTM)
- -3.00
- Beta
- 0.18
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 0
- Revenue growth
- 0.00%
- Free cash flow
- -12.00M
- Total cash
- 24.77M
- Total debt
- 0
- Return on equity
- -54.06%
- Shares outstanding
- 5.85M
- Short % of float
- 0.18%
- 50-day average
- 0.96552
- 200-day average
- 1.77
Analyst view
Consensus: none
Next earnings
Dec 23, 2024
Expected Dec 23, 2024. Consensus EPS estimate 0.00.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Dec 23, 2024 | Sep 1, 2024 | 0.00 | — | — | — |
| Oct 4, 2024 | Jun 1, 2024 | 0.00 | — | — | — |
| Jul 4, 2024 | Mar 1, 2024 | -0.17 | — | — | — |
| May 15, 2024 | Dec 1, 2023 | 0.00 | -0.62 | — | — |
| Nov 27, 2023 | Sep 1, 2023 | -0.30 | -0.44 | -0.14 | -46.67% |
| Aug 4, 2023 | Jun 1, 2023 | -0.45 | -0.95 | -0.50 | -111.11% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jun 7, 2023 | HC Wainwright & Co. | down | Buy | Neutral |
| May 15, 2023 | HC Wainwright & Co. | reit | Buy | Buy |
| Apr 5, 2023 | HC Wainwright & Co. | reit | — | Buy |
| Aug 9, 2021 | HC Wainwright & Co. | main | — | Buy |
| Mar 17, 2021 | Dawson James | down | Buy | Neutral |
| Mar 16, 2021 | HC Wainwright & Co. | main | — | Buy |
About Check-Cap Ltd.
Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. The company was incorporated in 2004 and is based in Isfiya, Israel.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Country
- Israel
- Website
- check-cap.com
News
- Accuray (NASDAQ:ARAY) & Check-Cap (NASDAQ:CHEK) Critical Analysis
- MBody AI ($CHEK) Secures 98% Shareholder Approval to Become Leading Nasdaq Embodied AI Company
- 12 Health Care Stocks Moving In Friday's After-Market Session
- MBody AI ($CHEK) Expands Global Leadership in Embodied AI With Major Wins
- RETRANSMISSION: Check-Cap and MBody AI Advance Toward Closing Transformational Merger
- 12 Health Care Stocks Moving In Tuesday's After-Market Session
- 12 Health Care Stocks Moving In Monday's After-Market Session
- 12 Health Care Stocks Moving In Monday's Intraday Session
- Stock Market Today: S&P 500, Nasdaq, Dow Futures Rise— Nvidia, Hain Celestial, Check Cap In Focus (UPDATED)
- 12 Health Care Stocks Moving In Monday's Pre-Market Session
Your note
Sign in to keep a note on CHEK — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| UBS Group AG | 0.07% | 4,102 | 9.23K | Sep 29, 2024 |
| JP Morgan Chase & Company | 0.03% | 1,500 | 3.38K | Sep 29, 2024 |
| Osaic Holdings Inc | 0.03% | 1,622 | 3.65K | Sep 29, 2024 |
| Morgan Stanley | 0.03% | 1,662 | 3.74K | Sep 29, 2024 |
| IFP Advisors, Inc | 0.01% | 500 | 1.13K | Jun 29, 2024 |
| Bank of America Corporation | 0.01% | 300 | 675 | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| DFA U.S. Micro Cap Series | 0.15% | 8,958 | 20.16K | Jul 30, 2024 |
| Fidelity NASDAQ Composite Index Fund | 0.05% | 2,932 | 6.60K | Oct 30, 2024 |